[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366511-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366511-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","liver-specific-lncrnas-associated-with-liver-cancers-review","Liver-specific lncRNAs associated with liver cancers - review","","Long non-coding RNAs (lncRNAs) exceed 200 nucleotides and do not encode proteins, yet they regulate gene expression through mechanisms such as protein scaffolding, microRNA sponging, and interactions with mRNAs, other lncRNAs, or DNA promoters. Their expression often shifts under stress, metabolic changes, development, and carcinogenesis, making cancer-associated lncRNAs promising biomarkers. This review focuses on lncRNAs with preferential expression in liver and liver tumors, summarizing recent findings on their dysregulation and underlying cellular mechanisms for potential liver cancer diagnostics and prognosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/liver-specific-lncrnas-associated-with-liver-cancers-review/366511/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/liver-specific-lncrnas-associated-with-liver-cancers-review/366511.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes liver-specific lncRNAs useful as cancer biomarkers?","Question",{"text":63,"@type":64},"lncRNAs show stronger tissue specificity than proteins, and many are dysregulated in liver tumors. Liver-preferential lncRNAs can support more specialized diagnostics and prognosis than universally dysregulated ones.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which biological mechanisms do lncRNAs use to regulate gene expression?",{"text":68,"@type":64},"lncRNAs can act through protein scaffolding, sponging microRNAs, binding mRNAs or other lncRNAs, and direct interaction with DNA promoters.",{"name":70,"@type":61,"acceptedAnswer":71},"How are recent liver cancer lncRNAs different from well-known universal oncogenic lncRNAs?",{"text":72,"@type":64},"Universal lncRNAs are dysregulated across multiple malignancies, reducing liver-specific diagnostic value. The review highlights other lncRNAs with preferential expression in liver and/or liver tumors, aiming to improve specialized biomarker relevance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366511,1790877280,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","REVIEW  \nLiver-speciﬁc lncRNAs associated with liver cancers  \nOlga Y. Burenina 1,2,3 , Roman K. Makarchenko2, Maria P. Rubtsova2,3 and Olga A. Dontsova 1,2,3   \n1 Center of Molecular and Cellular Biology, Moscow, Russia  \n2 Chemistry Department, Lomonosov Moscow State University, Russia  \n3 Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia  \nKeywords  \nbiomarkers; hepatocellular carcinoma; liver cancer; long noncoding RNA  \nCorrespondence  \nO. Y. Burenina, Center of Molecular and Cellular Biology, Bolshoy Blvd 30 Bld1, Moscow 121205, Russia  \nE-mail: [alunit@inbox.ru](alunit@inbox.ru); Tel: +74959328824;  \nFax: +74959395359  \n(Received 29 October 2024, revised 29 April 2025, accepted 16 June 2025)  \ndoi:10.1002/2211-5463.70079  \nEdited by Marcin Majka  \nLong non-coding RNAs (lncRNAs) are transcripts with a length more than 200 nt, which do not encode proteins and act just as RNA molecules. In general, lncRNAs have much more distinct tissue speciﬁcity than proteins, as they usually realize more peculiar regulatory functions. Their expression levels are often altered in a response to stress conditions, metabolic changes, development of different diseases, and carcinogenesis. Cancer-associated lncRNAs are widely considered as perspective and useful biomarkers. Thus, development of clinical tests, which include tissue-speciﬁc and cancer-speciﬁclncRNAs, might signiﬁcantly contribute to cancer diagnostics and/or prognosis of the disease. A number of lncRNAs is known to be dysregulated in liver tumors and considered as probable biomarkers. However, most of them are rather universally well-known lncRNAs associated with various cancers. In the present review, we aimed to shed light on other lncRNAs with preferential expression in liver and/or liver tumors, for example, LINC01554, LINC01093, LINC01348, LINC02428, FAM99B, etc. We summarized recent discoveries unveiling their dysregulation in liver malignancies and related cellular mechanisms in which they are involved and considered their signiﬁcance as probable liver cancer biomarkers.  \nLncRNAs comprise a heterogeneous class of transcripts with a length of more than 200 nt, which do not undergo translation. They act as regulatory RNA molecules through various mechanisms, including protein scaffolding, sponging microRNAs, interacting with mRNAs or other lncRNAs, or via direct binding to DNA promoters [1,2] . Being a powerful tool for the regulation of gene expression, lncRNAs are largely involved in a number of key cellular processes, in particular those mechanisms speciﬁc to various pathogenic conditions and carcinogenesis [3–5] . Thus, lncRNAs are widely considered in terms of cancer therapy and diagnostics [6] . Besides, some of them are secreted in blood  \nand might be used as noninvasive oncomarkers [7] . So far, only a single lncRNA – PCA3 is already used in routine clinical tests as an efﬁcient oncomarker for prostate cancer, which has exclusive tissue speciﬁcity and cancer speciﬁcity and can be directly detected in urine samples [8] . Indeed, tissue speciﬁcity is more pronounced for lncRNAs than for proteins according to RNA-Seq data, even considering only normal human tissues [9–11] . Additionally, different types of tumors express different sets of lncRNAs, and at least some novel candidates can appear to be unique to distinct malignancies; thus, they are a powerful tool for their speciﬁc diagnostics and potential targets for cancer therapy [12,13] .  \nAbbreviations  \nAFP, alpha-fetoprotein; CCA, cholangiocarcinoma; ceRNA, competitive endogenous RNA; EMT, epithelial–mesenchymal transition; HBL, hepatoblastoma; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; lncRNA, long noncoding RNA; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; nt, nucleotides; RIP, RNA immunoprecipitation; TCGA, The Cancer Genome Atlas.  \nFEBS Open Bio 15 (2025) 1383–1405 ª 2025 The Author(s) . ","cbCaip2JOqiMA2Q4","https://ap.wps.com/l/cbCaip2JOqiMA2Q4","pdf",1169450,23,"English","# Introduction\n## Biological roles of lncRNAs in cancer\n## Tissue and cancer specificity as diagnostic rationale\n# Liver-specific lncRNAs and dysregulation in liver malignancies\n## Liver tumor lncRNAs in hepatocellular carcinoma and cholangiocarcinoma\n## Common universal oncogenic lncRNAs vs liver-specific candidates\n# Spotlight on HULC and emerging liver-specific lncRNAs\n## HULC as a highly upregulated liver cancer marker\n## Diagnostic/prognostic potential and ongoing functional studies\n# Abbreviations","[{\"question\":\"What makes liver-specific lncRNAs useful as cancer biomarkers?\",\"answer\":\"lncRNAs show stronger tissue specificity than proteins, and many are dysregulated in liver tumors. Liver-preferential lncRNAs can support more specialized diagnostics and prognosis than universally dysregulated ones.\"},{\"question\":\"Which biological mechanisms do lncRNAs use to regulate gene expression?\",\"answer\":\"lncRNAs can act through protein scaffolding, sponging microRNAs, binding mRNAs or other lncRNAs, and direct interaction with DNA promoters.\"},{\"question\":\"How are recent liver cancer lncRNAs different from well-known universal oncogenic lncRNAs?\",\"answer\":\"Universal lncRNAs are dysregulated across multiple malignancies, reducing liver-specific diagnostic value. The review highlights other lncRNAs with preferential expression in liver and/or liver tumors, aiming to improve specialized biomarker relevance.\"}]","Liver-specific lncRNAs associated with liver cancers - review | PDF",1790165882,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f21c916bbccd699d2811f5f8f5975976.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38c3b599856fe0d1aaadf4419d26f759.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf2583d90e08d2c86475de9b789ab920.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/383d021ec4c1afecfb2ebaa09ee9d472.webp",980,1287]